New AstraZeneca Data Presented at ATS 2023 Strengthen the Body of Evidence Supporting Early Intervention With BREZTRI in COPDBusiness Wire • 05/23/23
Revvity Announces New License Agreement for Next-Generation Base Editing TechnologyBusiness Wire • 05/18/23
AstraZeneca disappointed by US panel recommendation for prostate cancer drugProactive Investors • 05/02/23
AstraZeneca is now bigger than Pfizer, but what's the secret of CEO Soriot's success?Proactive Investors • 04/24/23
AstraZeneca results arrive with focus on drug trials, while GSK still faces Zantac overhangProactive Investors • 04/21/23